Hachiouji, Japan

Hidefumi Ozawa



 

Average Co-Inventor Count = 7.9

ph-index = 3

Forward Citations = 45(Granted Patents)


Location History:

  • Hachiouji, JP (2003 - 2007)
  • Tokyo, JP (2011)

Company Filing History:


Years Active: 2003-2011

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Hidefumi Ozawa

Introduction

Hidefumi Ozawa is a prominent inventor based in Hachiouji, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target various health conditions. With a total of 5 patents to his name, Ozawa's work is recognized for its potential therapeutic applications.

Latest Patents

Ozawa's latest patents include innovative compounds such as 2-oxochromene derivatives. This invention aims to provide a novel LXRβ agonist that can serve as a preventative and therapeutic agent for a range of conditions, including atherosclerosis, dyslipidemia, and Alzheimer's disease. Another notable patent is a PPAR-activating compound, which selectively activates PPARα and is designed to be used as a medicament. This compound is represented by a benzoic acid derivative that has various applications in treating metabolic disorders.

Career Highlights

Ozawa is currently associated with Kowa Company Limited, where he continues to advance his research and development efforts. His work has been instrumental in creating compounds that address significant health challenges, showcasing his expertise in medicinal chemistry.

Collaborations

Some of his notable coworkers include Ayumu Okuda and Yukiyoshi Yamazaki, who have collaborated with him on various projects, contributing to the success of their research endeavors.

Conclusion

Hidefumi Ozawa's innovative contributions to medicinal chemistry highlight his role as a key inventor in the field. His patents reflect a commitment to developing effective therapeutic agents that can improve health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…